fbpx
May 19, 2023

TNF, JAK Inhibitors’ CV Safety Compared in PsA, AxSpA TNF, JAK Inhibitors’ CV Safety Compared in PsA, AxSpA

CLEVELAND – Patients with axial spondyloarthritis or psoriatic arthritis who used Janus kinase (JAK) inhibitors did not have higher risk of myocardial infarction, stroke, or venous thromboembolism […]
May 19, 2023

AMA President on Fighting Prior Auth, Scope Creep, and More AMA President on Fighting Prior Auth, Scope Creep, and More

The president of the American Medical Association (AMA), Jack Resneck Jr, MD, met with Medscape editors to discuss pressing topics in healthcare. Resneck, a practicing dermatologist […]
May 19, 2023

FDA Approves Epcoritamab for r/r B-Cell Lymphoma FDA Approves Epcoritamab for r/r B-Cell Lymphoma

The US Food and Drug Administration approved epcoritamab (DuoBody, AbbVie and GenMab) today for adults with relapsed/refractory diffuse large B-cell lymphoma following at least two lines […]
May 19, 2023

SCAI Drafts Guidance on Renal Denervation for Hypertension SCAI Drafts Guidance on Renal Denervation for Hypertension

Anticipating US Food and Drug Administration (FDA) approval of at least one investigational device for renal denervation (RDN) as a treatment for hypertension (HTN) refractory to […]
May 19, 2023

FDA Roundup: May 19, 2023

For Immediate Release: May 19, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the […]
May 19, 2023

FDA Clears iLet Bionic Pancreas Insulin Delivery System FDA Clears iLet Bionic Pancreas Insulin Delivery System

The US Food and Drug Administration (FDA) has cleared Beta Bionics’s iLet ACE Pump and the iLet Dosing Decision Software for people ages 6 years and […]
May 19, 2023

King Bio Inc. – 567480 – 03/20/2019

Product: Drugs Recipient: Recipient Name Dr. Frank King, Jr Recipient Title President King Bio Inc. 3 Westside DriveAsheville, NC 28806United States Issuing Office: Division of Pharmaceutical […]
May 19, 2023

FDA approves treatment for relapsed or refractory diffuse large B-cell lymphoma and high-grade B-cell lymphoma

Action FDA has approved Epkinly (epcoritamab-bysp) injection for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, including […]
May 19, 2023

Alpha Feed Mill, Inc – 570812 – 03/04/2019

Product: Animal & VeterinaryDrugs Animal Feed Recipient: Recipient Name Brice R. Weber Recipient Title Co-Owner and President Alpha Feed Mill, Inc 2741 North 150 AvenueAlpha, IL […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0